Stock Analysis on Net
Stock Analysis on Net

AstraZeneca PLC (NYSE:AZN)

This company has been moved to the archive! The financial data has not been updated since March 10, 2015.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

AstraZeneca PLC, common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Current interest-bearing loans and borrowings 4.17 3.20 1.68 3.77 0.22
Trade payables 5.96 4.47 4.57 4.08 4.02
Value added and payroll taxes and social security 0.34 0.37 0.43 0.65 0.58
Rebates and chargebacks 6.02 5.10 4.64 6.22 5.06
Accruals 5.51 6.45 5.98 4.68 4.09
Other payables 2.44 2.14 1.60 1.36 1.68
Trade and other payables 20.29% 18.54% 17.22% 16.99% 15.43%
Derivative financial instruments 0.04 0.00 0.01 0.02 0.01
Provisions 1.06 1.47 1.71 2.63 1.95
Income tax payable 4.02 5.50 5.35 6.42 12.29
Current liabilities 29.58% 28.71% 25.97% 29.82% 29.91%
Non-current interest-bearing loans and borrowings 14.33 15.36 17.58 13.89 16.21
Derivative financial instruments 0.00 0.00 0.00 0.00 0.00
Deferred tax liabilities 3.07 5.06 4.81 5.18 5.60
Retirement benefit obligations 5.04 4.04 4.23 5.06 4.40
Provisions 0.83 1.01 0.80 0.90 1.50
Accruals 0.37 0.23 1.33 0.21 0.19
Other payables 13.26 3.98 0.54 0.51 0.48
Trade and other payables 13.64% 4.21% 1.87% 0.73% 0.66%
Non-current liabilities 36.90% 29.69% 29.29% 25.75% 28.38%
Total liabilities 66.47% 58.40% 55.26% 55.57% 58.29%
Share capital 0.54 0.56 0.58 0.61 0.63
Share premium account 7.27 7.13 6.55 5.83 4.76
Capital redemption reserve 0.26 0.27 0.29 0.26 0.19
Merger reserve 0.76 0.77 0.81 0.82 0.77
Other reserves 2.42 2.47 2.57 2.61 2.45
Retained earnings 22.24 30.34 33.55 33.87 32.55
Capital and reserves attributable to equity holders of the Company 33.50% 41.55% 44.34% 44.00% 41.36%
Non-controlling interests 0.03 0.05 0.40 0.43 0.35
Total equity 33.53% 41.60% 44.74% 44.43% 41.71%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. AstraZeneca PLC current liabilities as a percentage of total liabilities and equity increased from 2012 to 2013 and from 2013 to 2014.
Non-current liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. AstraZeneca PLC non-current liabilities as a percentage of total liabilities and equity increased from 2012 to 2013 and from 2013 to 2014.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. AstraZeneca PLC total liabilities as a percentage of total liabilities and equity increased from 2012 to 2013 and from 2013 to 2014.
Capital and reserves attributable to equity holders of the Company Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. AstraZeneca PLC capital and reserves attributable to equity holders of the Company as a percentage of total liabilities and equity decreased from 2012 to 2013 and from 2013 to 2014.